Moreover, transfection of miRNAs or miRNA inhibitors have beneficial effects on alleviating CD4+T cell disease phenotype, highlighting the important role of miRNAs in lupus-like CD4+T phenotype transformation. This evidence concerns the gene CD4 and systemic lupus erythematosus.